Immune checkpoint inhibitor related myositis: an observational, retrospective, pharmacovigilance study
CONCLUSIONS: Clinicians should be aware of the potential for ICI-associated myositis, as it can be particularly life-threatening, especially in elderly patients or when it occurs concurrently with other AEs such as myocarditis or severe myasthenia gravis.PMID:38629402 | DOI:10.1080/14740338.2024.2343023
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Hezhe Lu Hui Yang Zhexin Ding Zhuoling An Yong Zhao Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Drugs & Pharmacology | Myasthenia Gravis | Myocarditis | Study